Welcome to our open innovation community where academic groups and (biotech & medtech) startups developing ATMPs and medical devices are getting ready for clinical manufacturing. Read some testimonials of current and previous Medace clients below.
“We hope to replace the insulin syringe with an innovative method and aim to bring a combination of an implant and cell therapy to the market for people with severe type I diabetes. Medace’s role is to facilitate logistics, clean rooms and quality systems.”
Aart van ApeldoornAssistant Professor Maastricht University / RegMed XB
“We are excited to perform our ATMP manufacturing at the Medace facilities. Their innovative business model which reduces risks and large investment suits InoCells best. Medace’s products and services such as lab facilities, GMP-ready clean rooms, quality management & regulatory support and its network with key partners, enables InoCells to reduce its time to market. InoCells is looking forward to a long-term collaboration with Medace.”
Mohammad Mehdi AkhondiManaging Director InoCells
“At PL BioScience, we highly value the cooperation with Medace. The innovative and inspiring work environment gives us the opportunity to enhance the development of tomorrow's cell culture tools. That perfectly matches our mission to promote an animal-free future of cell culture solutions.”
Hatim HemedaCEO and founder PL BioScience GmbH
“We are taking the next step in our quest to deliver the highest quality mRNA! Together with our partner, Medace, we adapting our process to GMP-standards, with the goal to support our customers from bench-to-bedside.”
Sander van AsbeckCEO RIBOPRO
“The use of Medace’s facility and support helped us at Biomedical Bonding to quickly and efficiently set up controlled cleanroom manufacturing of our AdhFix implant – a customizable composite bone plate. Medace’s services allowed us to swiftly produce devices for our design validation activities, optimizing our product development from a time, risk and resource perspective.”
Viktor Granskog, PhDCTO Biomedical Bonding AB
“We look forward to continue working together with Medace, building a mutually beneficial relationship in order to advance medical device and ATMP developments in Europe.”
Sarah TsurkanFounder TissueGuard GmbH
“The Medace support offers us a great way to progress and strengthen the pipeline of our fast-growing company and to deliver true quality to and with our partners.”
Robert Jan LamersCEO Orthros Medical
“The collaboration with Medace is our next important step in the development of technologies implemented by Chitomed B.V. Chitomed B.V. is focused on developing and implementing innovative technologies and medical devices from biomaterials into clinical practice. In the Netherlands, we found the ideal ecosystem for such an activity. Medace, with its competent, friendly team and set of specialized laboratories, is an important part of this ecosystem.”
Edyta WątrobińskaManaging director Chitomed
“Our collaboration with Medace is a game-changer for SwiftPharma. We're working on improving the production promising medicinal proteins using plant-based biomanufacturing, and Medace's accessible GMP manufacturing facility, along with their support for quality and regulatory is invaluable. This partnership is helping us get these important products out faster, making a real impact on people's lives.”
Jeroen HofenkFounder & CSO
“For us the facilities and services Medace has to offer came just at the right time. We are quickly expanding, and this gives us the flexibility to continue today while preparing tomorrow.”
Peter VerstrateCOO Mosa Meat
“The facilities and expertise at Medace are great, the communication lines are short and there is a high degree of flexibility. This makes Medace an ideal partner for us at this stage of our development program.”
Ward van BuulCEO JointSphere
“Medace helps us to accelerate in a flexible and cost effective way with the pre-clinical tests of our product through the usage of their advanced Research and Development facilities. This allows us to focus on the test results without having to make large capital expenses. We look forward to the intense collaboration and to learning from these qualified professionals.”
Jan HunikCEO Atro Medical
“It’s great to see how the extraordinary collaborations we are advocates of – uniting researchers and entrepreneurs from all background and disciplines - have become a matter of course at Medace.”
Emiel StaringManaging Director Chemelot Institute for Science and Technology (InSciTe)
“Medace facilitates us, to process ocular tissues in a standardized, high quality manner, by using state-of-the-art equipment within a certified quality and regulatory system. This increases the quality and validity of the work in preparation for a first-in-man study”
Christian J.F. BertensCSO PEYEONEER MedTech
“The Medace facility offers us a nice way to integrate the manufacturing into our fast growing company while minimizing the risk and resources of running such a facility ourselves”
John MaruggCEO Corporis Medical
“We have recently signed a number of very large contracts and need to scale up. Medace has the necessary knowledge and experience and is therefore the right partner for Medprotex to set up our quality systems and to guarantee our future quality levels. We look forward to continuing a successful collaboration!”
Nikolaj Boogaard and Cyrille DepondCo-founders Medprotex
“In the development of our equipment access to a well equipped laboratory with the necessary consumables and reagents is key. Through the flexible, plug and play model at Medace we can make use of the facilities when we need them without having to making large investments ourself upfront. This helps us to take the necessary steps and remove barriers which we would normal come across when investing in such facilities ourselves.”
Hugo NikkelBusiness Developer Next Generation Sensors
